Legal Representation
Attorney
JOSEPH SOFER, ESQ.
USPTO Deadlines
Next Deadline
216 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200721)
Due Date
July 21, 2026
Grace Period Ends
January 21, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 21, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Apr 12, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 10, 2020 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Nov 10, 2020 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| Oct 21, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 21, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 12, 2020 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| May 27, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| May 27, 2020 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 5, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 5, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 15, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 26, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 26, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 26, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 26, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 26, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 25, 2020 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | Loading... |
| Mar 25, 2020 | GNSF | O | SUBSEQUENT FINAL EMAILED | Loading... |
| Mar 25, 2020 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | Loading... |
| Mar 5, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 5, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 2, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 26, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 5, 2019 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Sep 5, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 6, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 6, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 8, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 20, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 20, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 8, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 7, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2019 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | Loading... |
| Jan 29, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 28, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 24, 2019 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | Loading... |
| Jan 9, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 8, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 8, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 3, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 3, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 27, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemical preparations for discovery of new pharmaceutical products, not for medical use; diagnostic preparations used in science; diagnostic reagents for scientific use; test kits for analysis and diagnosis for scientific use and for use in the field of research, namely, reagents and buffers; chemical compounds for scientific use and for use in the field of research, and not for medical use, namely, oligonucleotides, polynucleotides, synthetic genes; oligonucleotide sequences for DNA microchips; gene libraries, namely, collections and variations of DNA fragments for scientific use; genetic engineering materials, namely, genes, fragments and combinations thereof for scientific use
Class 005
Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary use, namely, reagents used for immunological methods, for the identification and quantification of protein type structures and fragments thereof; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides and polynucleotides for medical and veterinary use; synthetic genes for medical and veterinary use; oligonucleotide sequences for DNA microchips for medical and veterinary use; gene libraries, namely, collections and variations of DNA fragments for medical and veterinary use, genetic engineering materials, namely, genes, fragments and combinations thereof for medical and veterinary use
Class 009
DNA chips; peptide chips; DNA microchips; peptide microchips; biochips
Class 042
Research and development in the fields of animal and plant biology, physical chemistry and microbiology; carrying out physical, chemical, physical-chemical, biochemical, biological or microbiological analyses in the fields of plant and animal products; carrying out physical, chemical, physical-chemical, biochemical, biological or microbiological analyses in the field of the food, chemical, pharmaceutical, cosmetic and environmental industry; carrying out genetic analyses in the fields of plant and animal products; carrying out genetic analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; carrying out nuclear magnetic resonance analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; scientific and industrial research; development of methods, namely, establishment and maintenance of chemical, biological and biomolecular testing methods; providing scientific, medical or industrial expert reports by scientists and engineers in the field of chemistry, biochemistry, immunology, pharmacology, biology and physiology for scientists and engineers; technical project studies; professional consultations in the field of scientific research and treatments in the field of chemistry, biochemistry, immunology, pharmacology, biology and physiology
Additional Information
Design Mark
The mark consists of "EUROFINS DISCOVERX" with a vertical line between the terms and a dotted design to the left of the word "EUROFINS. DISCOVERX" is placed slightly lower than the word "EUROFINS".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
EURO FINS DISCOVER X
Classification
International Classes
001
005
009
042